April 3, 2003 — ELISPOT, an enzyme-linked immunospot that detects T cells specific for Mycobacterium tuberculosis antigens, promises to be a major advance in screening for tuberculosis (TB), according ...
A new blood test, Enzyme-linked immunospot (ELISpot), is found to be more effective in diagnosing tuberculosis (TB) than the traditional skin tests. Tuberculosis is an infectious bacterial disease, ...
Austin, June 18, 2025 (GLOBE NEWSWIRE) -- ELISpot and Fluorospot Assay Market Size & Growth Analysis: According to SNS Insider, the global ELISpot and Fluorospot Assay Market was valued at USD 290.92 ...
The Elispot and Fluorospot Assay Market is witnessing steady growth owing to its vital role in immunological research and clinical diagnostics. These assays offer high sensitivity and specificity in ...
Dublin, Feb. 07, 2024 (GLOBE NEWSWIRE) -- The "ELISpot and FluoroSpot Assay Market - Global Forecast to 2028" report has been added to ResearchAndMarkets.com's offering. The global ELISpot and ...
ProImmune Ltd. has launched the B cell ELISpot assay as a service. The B cell ELISpot assay is central to the characterization of adaptive immune responses to infection, immune modulators, vaccines ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results